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The β1-adrenergic receptor (β1-AR) mRNAs are post-transcriptionally regulated at the level of mRNA stability and undergo accelerated
agonist-mediated degradation via interaction of its 3′ untranslated region (UTR) with RNA binding proteins, including the HuR nuclear protein. In
a previous report [Kirigiti et al. (2001). Mol. Pharmacol. 60:1308–1324], we examined the agonist-mediated down-regulation of the rat β1-AR
mRNAs, endogenously expressed in the rat C6 cell line and ectopically expressed in transfectant hamster DDT1MF2 and rat L6 cells. In this
report, we determined that isoproterenol treatment of neonatal rat cortical neurons, an important cell type expressing β1-ARs in the brain, results in
significant decreases in β1-AR mRNA stability, while treatment with leptomycin B, an inhibitor of the nuclear export receptor CRM 1, results in
significant increases in β1-AR mRNA stability and nuclear retention. UV-crosslinking/immunoprecipitation and glycerol gradient fractionation
analyses indicate that the β1-AR 3′ UTR recognize complexes composed of HuR and multiple proteins, including CRM 1. Cell-permeable
peptides containing the leucine-rich nuclear export signal (NES) were used as inhibitors of CRM 1-mediated nuclear export. When DDT1MF2
transfectants were treated with isoproterenol and peptide inhibitors, only the co-addition of the NES inhibitor reversed the isoproterenol-induced
reduction of β1-AR mRNA levels. Our results suggest that CRM 1-dependent NES-mediated mechanisms influence the degradation and agonist-
mediated down-regulation of the β1-AR mRNAs.
© 2006 Elsevier B.V. All rights reserved.Keywords: β1-adrenergic receptor; CRM 1; mRNA degradation and stability; Agonist-induced down-regulation1. Introduction
Post-transcriptional regulatory mechanisms participate in the
stability and degradation of various cellular RNAs [1–4].
Several G protein-coupled receptor (GPCR) mRNAs, including
those encoding theβ1- andβ2-adrenergic receptors (ARs) [5–7],
undergo agonist-induced decreases in transcript stability. The
β2-AR mRNA contains an AU-rich 3′ UTR that can recognize
several RNA binding proteins, including (1) the β-adrenergic
receptor mRNA-binding protein (βARB), a cytosolic protein
that requires both AUUUA pentamers and U-rich domains for
RNA recognition, (2) the Mr 37,000 RNA degradation factor⁎ Corresponding author. Department of Integrative Biosciences, School of
Dentistry, Oregon Health & Science University, 611 SW Campus Drive,
Portland, Oregon 97239, USA. Tel.: +1 503 494 0034; fax: +1 503 494 8554.
E-mail address: machidac@ohsu.edu (C.A. Machida).
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doi:10.1016/j.bbamcr.2006.08.009AUF1, and (3) the T-cell-restricted intracellular-related protein
(TIAR), a molecule involved in translational control [5–11]. In
the presence of β-AR agonist isoproterenol, βARB and AUF1
appear to be up-regulated, concomitant with the down-
regulation of β2-AR mRNA. Specific AU-rich elements in the
β2-AR 3′ UTR, including a 20 bp core sequence, have been
demonstrated to be essential for the agonist-mediated destabi-
lization of β2-AR mRNA [12–14]. Using chimeric receptor–
beta globin recombinants, the human β1-AR mRNA 3′ UTR
was determined to target β-globin mRNA for accelerated decay,
and was demonstrated to be necessary but not sufficient for
agonist-mediated destabilization of transcripts [15]. Using mass
spectrometry, βARB has been identified as a complex protein
mixture consisting of HuR and hnRNPA1 [16]. HuR appears to
be the predominant RNA binding component of βARB;
however, the precise component composition of βARB appears
to be dependent on the 3′ UTR sequence of the target β-AR
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AR translation and provides further validation of the growing
body of evidence linking ARE binding proteins to roles in post-
transcriptional control mechanisms, including RNA degrada-
tion and translation [10,11].
Cellular mRNAs are transported through the nuclear pore by
interaction of complexes containing export receptor proteins
and adapter molecules [17–21]. RNA binding proteins that
serve as potential adapters include HuR, hnRNPA1, hnRNP K,
SRP20, 9G8, and ASF/SF2 [22–26]. HuR selectively binds
AREs and promotes the stabilization of many ARE-containing
mRNAs, including those that encode c-fos, c-myc, tumor
necrosis factor alpha, cyclooxygenase 2, myogenins, interleu-
kins, vascular endothelial growth factor, and granulocyte-
macrophage colony stimulating factor [27–29]. HuR has been
implicated in the regulation of a wide assortment of cellular
responses, including cell division, immune cell activation and
carcinogenesis [28]. HuR, predominantly localized in the
nucleus, can shuttle between the nuclear and cytoplasmic
compartments; however, the major influence of HuR on mRNA
stabilization and translation appears to be dependent on its
cytoplasmic localization [28–30]. HuR contains three RNA
recognition motifs (RRMs). ARE recognition appears to be
mediated by the first two RRMs, while the third RRM is
believed to interact with the poly (A) tail of the targeted mRNA
[27,29]. HuR undergoes nucleocytoplasmic shuttling using a
novel shuttling sequence (HNS) located in the hinge region
between the second and third RRMs [27,29]. The ability of HuR
to undergo nucleocytoplasmic export has implicated that HuR
may bind ARE-containing mRNAs in the nucleus for export to
the cytoplasm. Four HuR ligands have been recently identified
by affinity chromatography: SETα and SETβ, pp32, and acidic
protein rich in leucine (APRIL) [31]. All four HuR ligands have
been found to form a multi-subunit heterocomplex with HuR;
similar heterocomplexes containing SETα, SETβ, and pp32
possess histone acetyltransferase inhibitory activity and roles in
chromatin remodeling and transcriptional regulation [32]. Three
of the HuR ligands (SETα, SETβ, and pp32) are inhibitors of
protein phosphatase 2A (PP2A). Human–mouse heterokaryon
fusion experiments and fluorescence-based nucleocytoplasmic
transfer assays demonstrate that HuR, pp32, and APRIL
undergo nucleocytoplasmic export [31]. Using cell permeable
peptide inhibitors, HuR nucleocytoplasmic export was deter-
mined to involve the association of HuR with pp32 and APRIL;
both HuR ligands contain leucine-rich export signals (NES) that
are recognized by the export receptor chromosome maintenance
region 1 (CRM 1) [27,29,31,33,34]. In addition, immunopre-
cipitation experiments support the contention of direct interac-
tion of pp32 and APRIL with CRM 1. Inhibition of CRM 1 with
leptomycin B results in the partial nuclear retention of pp32 and
APRIL, and also results in the increased association of HuR
with pp32 and APRIL and with nuclear poly (A) mRNA
[33,34]. In addition, the ARE-containing c-fos mRNAs become
partially retained in the nucleus following leptomycin B
treatment [33,34]. In total, these findings implicate CRM 1
and HuR as a nuclear export receptor–adapter in the nucleocy-
toplasmic export of ARE-containing mRNAs, and that themechanism of ARE-mediated mRNA degradation may be CRM
1-dependent and moderated by export of ARE-containing
mRNAs into the cytoplasm.
Nuclear export pathways that are CRM 1-independent may
also involve the HuR nucleocytoplasmic shuttling (HNS)
sequence within HuR; this shuttling sequence is similar to the
M9 shuttling sequence of hnRNP A1 [26,29,34]. HnRNP A1
contains a 39 amino acid M9 domain that interacts with nuclear
export receptor transportin 1 (Trn 1), a member of the importin
β family; this export receptor–adapter pair has been implicated
in the nuclear export of the dihydrofolate reductase mRNA
using Xenopus oocytes as a model system [35,36]. The nuclear
export receptor that recognizes HuR in this HNS-mediated
pathway has not been unequivocally defined [28]. However, the
nuclear import receptors for HuR, facilitated by interaction with
HNS, are transportin 1 and transportin 2 (Trn 1 and Trn 2,
respectively) [28,37,38].
In this report, we examined and compared the agonist-
mediated regulation of the rat β1-AR mRNAs in neonatal rat
cortical neurons and in established cell lines endogenously or
ectopically expressing β1-AR mRNAs. Nuclear transport and
cytoplasmic localization of cellular mRNAs have been
implicated as important determinants in mRNA stability. We
have provided evidence that CRM 1-mediated mechanisms,
including the use of leucine-rich export signals, are important
components in post-transcriptional β1-AR mRNA degradation
and agonist-mediated down-regulation.
2. Materials and methods
2.1. Cell lines, antibodies, chemicals, and statistical analyses
The rat C6 glioma (ATCC CCL 107) and hamster DDT1MF2 (ATCC CRL
1701) cell lines were cultured in Dulbecco's Modified Eagle medium (DMEM),
supplemented with 10% heat-inactivated fetal calf serum (FCS), 1% penicillin–
neomycin–streptomycin (PNS), and 1% L-glutamine. Low glucose (1.5 g/l) and
high glucose (4.5 g/l) DMEM were used to culture the C6 and DDT1MF2 cell
lines, respectively. DDT1MF2 cells transfected with the rat β1-AR expression
recombinant are described in Kirigiti et al. [7]. Antibodies recognizing HuR and
CRM 1 were obtained from Dr. Henry Furneaux (Cornell University School of
Medicine) and Dr. Gerard Grosveld (Department of Genetics, St. Jude
Children's Research Hospital, Memphis, TN), respectively. Both antibodies
were also obtained commercially from Santa Cruz Biotechnology (HuR
antibodies: sc-5261, mouse monoclonal IgG1 and CRM 1 antibodies: sc-5595
rabbit polyclonal IgG). Leptomycin B was purified and provided by Dr. Minoru
Yoshida (RIKEN, Japan) [39]. Statistical analyses to ascertain significance of
β1-AR mRNA half-lives were based on the two tailed unpaired t test derived
from the Microsoft Excel software program.
2.2. Preparation of neonatal rat cortical neuron cultures
Primary cultures containing neonatal rat cortical neurons were prepared
following methods described by Goforth et al. [40]. Briefly, cortices were
isolated from 1 to 2 day old Sprague–Dawley rats, minced in saline, trypsinized
for 10 min at 37 °C, and transferred to DMEM containing 4.5 g/l sucrose, 10%
fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2 mM
L-glutamine. The tissue was washed and dispersed by repeated triturations using
Pasteur pipets and low-speed centrifugations, followed by filtration of the final
suspension using an 88 μm nylon sieve. Cells were plated on poly-L-lysine
coated dishes (Fisher Scientific) and incubated at 37 °C in 5% CO2. Cells were
then treated for 48 h with ara-c (10 μm) to inhibit the growth of dividing cells,
primarily glial cells, and allowing for the isolation of neurons. Culture medium
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penicillin, 100 μg/ml streptomycin, and 5% horse serum, prior to use in
transfections and cell culture experiments.
2.3. RNA isolation, antisense probe preparation, and RNase
protection assay procedures
Methods for RNA isolation, quantitation, and determination of sample
integrity, and RNase protection assays (RPA) were conducted as described in
Yang and Machida [41]. The rat β1-AR mRNA has two functional
polyadenylation signals at +2450 and +2732. While the downstream
polyadenylation signal is highly preferred, the upstream polyadenylation signal
is utilized in most tissues analyzed and lies close to the midpoint of the 3′ UTR
sequence. Thus, to circumvent issues concerning probe utilization, the probe
pCS[−82, +273], which contains rat β1-AR sequence extending from position
−82 to +273 (relative to the translational start site), recognizes all β1-AR
transcripts and was used to measure total β1-AR mRNAs in RNase protection
experiments. Antisense transcripts were generated with T7 RNA polymerase
(20 Units, 37 °C, 1 h) using reaction components described in Yang and
Machida [41]. Total sample RNA (15 μg) was hybridized with antisense
transcripts (β1-AR cRNAs and cyclophilin cRNA) and digested with RNase T1
[41]. Ethanol-precipitated samples were suspended in formamide/dye solution
and the products separated by electrophoresis on a 5% acrylamide, 7 M urea gel.
RNase protection experiments were analyzed using the Biorad Molecular
Imager phosphorimager system and radioactive signals were converted into
digital quantitative values using the Quantity One software program. Intensity
values for β1-AR protected fragments were normalized with corresponding
intensity values for the cyclophilin-protected fragment obtained in the same
lane. Normalization ratios (β1-AR-protected fragment intensity/cyclophilin-
protected fragment intensity) for each lane were divided by the normalization
ratio determined for the lane corresponding to time 0. This second
normalization resulted in the assignment of the time 0 lane with a numerical
value of 1.0.
2.4. UV-crosslinking and immunoprecipitation of RNA–protein
complexes for SDS-polyacrylamide gel electrophoresis
Preparation of cell extracts, binding reactions, and UV-crosslinking of
RNA–protein complexes were conducted as described in Kirigiti and Machida
[42]. Noncovalently bound ribonucleotides were degraded using RNase T1
(1 U) and RNase A (1 μl of 0.5 μg/μl) for 30 min at 37 °C. The reaction mixtures
were added to equal volumes of 2× loading buffer (100 mM Tris–HCl, pH 6.8,
200 mM dithiothreitol, 4% sodium dodecyl sulfate (SDS), 2% bromophenol
blue, and 20% glycerol), boiled for 5 min, and subjected to electrophoresis in a
10% polyacrylamide gel (acrylamide:bis-acrylamide, 29:1; supplemented with
SDS). Gels were transferred to nitrocellulose membranes prior to phosphor-
imager analysis. Following UV-crosslinking of RNA–protein complexes and
RNase A/T1 digestion, 1–2 μl of specific antibody was added to the reaction
mix and allowed to incubate overnight at 4 °C. Phosphate buffered saline (PBS)
was added to the mixture and 20–40 μl of protein A slurry (protein A-Sepharose
4B beads; obtained from Sigma, catalogue #P3391) was then added, and
allowed to mix for 2 h at 4 °C. The protein A beads were then washed three times
by gentle centrifugation in PBS, and then resuspended in 6× loading buffer, prior
to heating at 100 °C for 2 min. RNA–protein complexes released from the
protein A beads were then loaded and electrophoresed in SDS-polyacrylamide
gels prior to phosphorimager analyses.
2.5. Electro-transfer to nitrocellulose membranes and immunoblotting
procedures
Proteins were electro-transferred onto nitrocellulose membranes, and blots
were blocked and prepared for immunostaining using procedures described in
Kirigiti et al. [43]. Primary antibodies include mouse monoclonals to HuR
(1:5000 dilution) and rabbit polyclonal to CRM 1 (1:2000 dilution). The primary
antibodies were then incubated for 2–5 h at room temperature with gentle
agitation. The secondary antibodies were anti-mouse HRP or anti-rabbit HRP
(1:10,000 dilutions). Membranes were then washed four times with 1× TTBS,and then developed using the Super-Signal Western pico chemiluminescence
substrate (Pierce Chemicals).
2.6. Cell lysis, glycerol gradient centrifugation, and immunoblot
procedures
Cell extracts using procedures known to preserve protein complexes were
previously described [31,44]. Briefly, cells were extracted with 5 ml lysis buffer
containing 25 mM HEPES–KOH, pH 8.0, 150 mM KCl, 2 mM EDTA, 1 mM
DTT, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 μg/ml pepstatin A,
20 mM NaF, and 0.1% NP-40. Extracts were clarified by centrifugation at
40,000 rpm (SW 50.1 rotor, Beckman) for 40 min. The supernatant was loaded
onto 4 ml 5–20% glycerol gradients and centrifuged at 40,000 rpm (SW 50.1
rotor, Beckman) for 12 h. Gradient fractions were then subjected to
polyacrylamide gel electrophoresis under nondenaturing conditions.
2.7. Cell-permeable peptides
Cell-permeable peptides contain the antenna-pedia internalization element
(AP=RQIKIWFQNRRMKWKK) at its amino-terminus. Peptides were
synthesized with COOH-extensions containing HNS (amino acids 205–237
of HuR; RRFGGPVHHQAQRFRFSPMGVDHMSGISGVNVP), NES
(amino acids 73–84 of the human immunodeficiency virus protein rev;
LQLPPLERLTLD); M9 (amino acids 268–305 of hnRNP A1; NQSSNFGP-
MKGGNFGGRSSGPYGGGGQYFAKPRNQGGY), and a scrambled HNS or
M9 sequence or a mutant NES with leucines 78 and 81 replaced by alanines, two
sites known to be essential for NES function. Peptides were synthesized and
purified by the Yale University Peptide Synthesis Facility.
3. Results and discussion
We have used an array of experimental methods to extend
our understanding of the molecular determinants underlying the
agonist-mediated degradation of the β1-AR mRNAs. Previous
work implicates the existence of at least three regulatory
mechanisms influencing β1-AR mRNA levels in C6 cells: (1)
an initial up-regulation induced by transcriptional activation, (2)
an intermediate down-regulation moderated by transcriptional
repression, potentially by inducible cyclic AMP early repressor
(ICER), and (3) a chronic down-regulation mediated by post-
transcriptional degradation mechanisms, potentially influenced
by HuR, a component of βARB and/or other RNA binding
proteins [7]. In our previous report, we provided evidence that
the mammalian elav-like protein HuR and the heteronuclear
protein hnRNPA1 interact with the β1-AR 3′ UTR and that the
induction of HuR by isoproterenol may play a role in the
agonist-mediated modulation of β1-AR mRNA half-life [7]. We
had also presented evidence that availability of specific protein
factors, including nuclear proteins and binding factors, may
play a role in both the steady-state and agonist-mediated
degradation of the β1-AR mRNAs, as observed with the
differential β1-AR mRNA half-lives seen in C6 cells, L6 cells,
and in the DDT1MF2 transfectants ectopically expressing β1-
ARs [7]. For this report, we wanted to extend our analysis to
neonatal rat cortical neurons, an important central nervous
system (CNS) cell type expressing β1-ARs, and provide
identification of additional molecular determinants in the post-
transcriptional degradation of the β1-AR mRNAs. We also
wanted to substantiate the importance of CRM 1-mediated
mechanisms of nuclear export in the agonist-mediated degrada-
tion of the β1-AR mRNAs.
1079Y. Bai et al. / Biochimica et Biophysica Acta 1763 (2006) 1076–10893.1. Isoproterenol treatment of neonatal rat cortical neurons
promotes decrease in β1-AR mRNA stability
Neonatal rat cortical neurons chronically treated with
isoproterenol (24 h) results in a significant decrease in β1-AR
mRNA stability (Fig. 1, Panels A–D). The β1-AR mRNA half-
lives for both steady state conditions and during chronic
isoproterenol treatment are 5.4 h±0.3 h and 3.0 h±0.2 h,
respectively (Fig. 1, Panels A–D). In a previous publication [7],
we reported the β1-AR mRNA half-lives for the rat glioma C6
cell line and for hamster DDT1MF2 transfectants ectopically
expressing β1-ARs under both steady state conditions and
following chronic isoproterenol treatment (see also Table 1). In
both cell lines, like in neonatal rat cortical neurons, the β1-AR
mRNAs underwent accelerated degradation following chronic
isoproterenol treatment (C6 cells: β1-AR mRNA half-lives are
63 min±1.7 min and 41 min±5.9 min for both steady state
conditions and during chronic isoproterenol treatment, respec-Fig. 1. β1-AR mRNA half-life determinations in neonatal rat cortical neurons: Pane
isoproterenol treatment, or neurons treated with leptomycin B (LMB). Panels A, C, a
(3 h) with actinomycin D following isoproterenol or LMB treatment to inhibit de no
levels. Gels were subjected to phosphorimager analyses. Normalization of β1-AR m
x- and y-axis for both graphs are time following actinomycin D treatment and nor
plotted on log scale to depict the first stage decline of β1-AR mRNA levels. Eac
derived and used to determine β1-AR mRNA half-lives under agonist treatment,tively; DDT1MF2 transfectants: β1-AR mRNA half-lives are
109 min±4.0 min and 83 min±5.1 min for both steady state
conditions and during chronic isoproterenol treatment, respec-
tively). These results confirm the importance of the availability
of specific protein factors on β1-AR mRNA stability under
both steady state conditions and during agonist-mediated
degradation.
3.2. Leptomycin B inhibition of CRM 1 nucleocytoplasmic
export in neonatal rat cortical neurons results in significant
increase in β1-AR mRNA stability
Leptomycin B (LMB) is an inhibitor of CRM 1 nucleo-
cytoplasmic export and results in the nuclear retention of
ARE-containing mRNAs, specifically c-fos mRNAs. Neonatal
rat cortical neurons treated with leptomycin B display
attenuated β1-AR mRNA half-lives of 16.4 h±1.1 h (Fig. 1,
Panels E and F).ls A, C, and E represent untreated controls, neurons undergoing chronic (24 h)
nd E depict representative RNase protection experiments. Neurons were pulsed
vo transcription. Panels B, D, and F: Normalization analyses of β1-AR mRNA
RNA levels against corresponding cyclophilin mRNA levels was conducted.
malized levels of β1-AR mRNA, respectively. Data points on the y-axis were
h data point was derived using 4 replicates. First-order decay equations were
leptomycin B treatment, or control conditions.
Table 1
β1-AR mRNA half life determinations under steady state conditions or under isoproterenol or leptomycin B induction
β1-AR mRNA half-life under treatment parameters
Steady state Isoproterenol Leptomycin
C6 cells 63 min±1.7 min (6)*(A) 41 min±5.9 min (6)*(B) 101 min±3.9 min (4)*(C)
DDT1MF2 transfectants 109 min±4 min (6)*(D) 83 min±5.1 min (6)*(E) 8.6 h±0.4 h (4)*(F)
Rat Cortical neurons 5.4 h±0.3 h (4)*(G) 3.0 h±0.2 h (4)*(H) 16.4 h±1.1 h (4)*(I)
* Numbers placed within parentheses represent number of experiments used in determination of β1-AR mRNA half-life values. Half-life determinations were based
on the equation: y=(intercept point on y-axis)×exp (mx) where y=percentage of β1-AR mRNA remaining; m=slope of the line; x=time (min). Statistical analyses
were based on the two-tailed unpaired t test. Half-life determinations for A, B, D, and E were previously published [7]. Statistical power of significance between A and
B (p=0.013) and between D and E (p=0.01) were also previously published [7]. New statistical analyses determined in this study: statistical power of significance
between A and C (p=0.00019); between E and F (p=0.00071); between G and H (p=0.0000025); between G and I (p=2.29E-09).
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export in DDT1MF2 transfectants results in significant
increases in β1-AR mRNA levels and half-life
Using leptomycin B treatment, we examined both steady-
state β1-AR mRNA levels and β1-AR mRNA stability in
DDT1MF2 transfectants, which ectopically express rat β1-ARs.
We observe a 10-fold increase in β1-AR mRNA levels in LMB-
treated DDT1MF2 transfectants, occurring in either the presence
or absence of isoproterenol (Fig. 2, Panels A and B). Using
actinomycin D (uc), an inhibitor of de novo transcription, we
have determined that the β1-AR mRNA half-life in LMB-
treated DDT1MF2 transfectants is 8.6±0.4 h (n=4 experiments;
Fig. 2, Panels C an D; also Table 1), and that the half-life is not
significantly different in the presence or absence of isoproter-
enol (8.2 h for LMB+isoproterenol). This is compared to the
β1-AR mRNA half-life of 109±4 min and 83±5.1 min
observed in DDT1MF2 transfectants cultured in the absence
or presence of isoproterenol, respectively (Fig. 2; also Table 1).
Leptomycin B inhibition of CRM 1 nucleocytoplasmic export
in DDT1MF2 transfectants also results in the significant
increase in β1-AR mRNA levels and transcript stability. In
addition, the lack of a synergistic isoproterenol-mediated effect
on β1-AR mRNA stability in leptomycin-treated cells indicates
that the agonist-mediated down-regulation of β1-AR mRNAs
may also be sensitive to LMB-inhibition of CRM 1 nucleocy-
toplasmic export. Alternatively, the isoproterenol-mediated
effect on β1-AR mRNA stability in leptomycin-treated cells
may potentially be too small or difficult to detect against the
much larger LMB-mediated decrease in β1-AR mRNA levels.
We also treated C6 cells, which endogenously express β1-AR
mRNAs, with leptomycin B to ascertain effects on β1-AR
mRNA stability. RNase protection experiments demonstrate that
C6 cells treated with leptomycin B also resulted in enhanced
β1-AR mRNA stability. β1-AR mRNA half-life determinations
in leptomycin-treated C6 cells were 101±3.9 min (n=4 expe-
riments), compared to β1-AR mRNA half-lives of 59.2±
3.4 min in matched non-treated C6 cell controls (n=4
experiments; Table 1). This is compared to β1-AR mRNA
half-lives of 63±1.7 min and 41±5.9 min in C6 cells cultured
in the absence or presence of isoproterenol, respectively. This
experiment provides additional validation that leptomycin
increases the stability of β1-AR mRNAs, and that the decreased
β1-AR mRNA stability may be moderated by cell type.3.4. Leptomycin B inhibition of CRM 1 nucleocytoplasmic
export in DDT1MF2 transfectants and in neonatal rat cortical
neurons results in significant retention of β1-AR mRNAs in the
nuclear fraction
Using matched parallel cultures, we have determined that
leptomycin B treatment of DDT1MF2 transfectants and
neonatal rat cortical neurons result in an enhanced retention
of β1-AR mRNAs in the nuclear fraction (10-fold increase for
leptomycin-treated DDT1MF2 tranfectants compared to
untreated controls; 3-fold increase for leptomycin-treated
neonatal rat cortical neurons compared to untreated controls)
(Fig. 3, Panel D and Fig. 4, Panel D). This experiment supports
the contention that leptomycin B inhibits the nucleocytoplasmic
export of β1-AR mRNAs in DDT1MF2 tranfectants ectopically
expressing β1-ARs and in the neonatal rat cortical neurons. We
believe that the leptomycin-induced nuclear retention of the
β1-AR mRNAs was greatly enhanced in the DDT1MF2
transfectants, because of the much higher levels of CRM 1 in
this cell line (see Fig. 7 for comparison). This observation is
consistent with the overall model implicating the role of CRM 1
in the nuclear export and subsequent down-regulation of the
β1-AR mRNAs (see below). In addition, for the DDT1MF2
transfectants, the observed decrease (25%) in β1-AR mRNA
levels following isoproterenol treatment, is statistically sig-
nificant (p=0.00004; Fig. 3); note that the standard error bars
for the histograms displaying the isoproterenol-treated and
untreated controls, are nearly indistinguishable from the height
of the histograms and accounts for the very high statistical
significance. Also, as expected, these observations are very
similar to the data displayed in Fig. 2, Panels A and B; we
determined that the difference between β1-AR mRNA levels in
isoproterenol-treated and untreated controls in this experiment
was also significant (p value=0.0015). However, for the
neonatal rat cortical neurons, the β1-AR mRNA levels in the
isoproterenol-treated and untreated controls are not significantly
different (Fig. 4, Panels A and B; p=0.551). We have previously
compared β1-AR mRNA levels in C6 cells, L6 cells, and
DDT1MF2 transfectants during steady state conditions and
following chronic isoproterenol treatment. As described in our
prior publication [7], steady-state β1-AR mRNA levels in the
DDT1MF2 transfectants were approximately 3-fold higher than
corresponding levels in C6 cells, and the isoproterenol-induced
reduction in the latter cells was small. Our RNase protection
Fig. 2. Panels A and B: Rat β1-AR mRNA levels in DDT1MF2 transfectants undergoing independent or concurrent treatment with isoproterenol and leptomycin.
Matched experiments using nontreated and isoproterenol-treated (without leptomycin) cells were also conducted in parallel with the leptomycin-treated cultures.
Experiments measure steady-state β1-AR mRNA levels in nontreated control cultures, isoproterenol-treated cultures (10 μg/ml, 24 h), leptomycin-treated cultures
(10 ng/ml, 24 h), and in cultures concurrently treated with isoproterenol (10 μg/ml, 24 h) and leptomycin (10 ng/ml, 24 h). Panel A depicts representative RNase
protection experiment. Panel B depicts statistical analyses of n=4 experiments. Error bars represent one standard error. Note that the standard error bars for the
histograms displaying the isoproterenol-treated and untreated control are indistinguishable from the height of the histograms. The observed decrease (54%) following
isoproterenol treatment is statistically significant (p=0.0015; see asterisk). Panels C–F: Rat β1-AR mRNA half-life analyses in DDT1MF2 transfectants undergoing
independent or concurrent treatment with isoproterenol (10 μg/ml, 24 h) and leptomycin (10 ng/ml, 24 h) followed by actinomycin D treatment (3 h) to inhibit de novo
transcription. Panels C and D depict representative RNase protection experiments of isoproterenol-treated, leptomycin-treated (±isoproterenol), or untreated cultures.
Samples were removed at designated times following the initiation of actinomycin D treatment. Panels E and F contain normalization calculations of β1-AR mRNA
levels against corresponding cyclophilin mRNA levels for isoproterenol-treated, leptomycin-treated (±isoproterenol), and untreated cultures. Error bars represent one
standard error. n=4 experiments for each treatment condition. Straight lines represent computer-generated first order decay for normalized levels of β1-AR mRNAs in
isoproterenol-treated, leptomycin-treated, isoproterenol/leptomycin-treated, and untreated cultures. Decay rate for β1-AR mRNAs in leptomycin-treated cultures and
cultures concurrently treated with leptomycin and isoproterenol are nearly identical.
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Fig. 3. β1-AR mRNA levels in DDT1MF2 transfectants: Total RNA (Panels A and B) or nuclear RNA (Panels C and D). Panels A and C depict representative RNase
protection experiments. For both experiments, DDT1MF2 transfectants were treated independently with isoproterenol (10 μg/ml, 24 h) or leptomycin (10 ng/ml, 24 h),
or concurrently with both isoproterenol (10 μg/ml, 24 h) and leptomycin (10 ng/ml, 24 h), or untreated. Degraded RNA in RNase protection assays would be evident as
smeared bands and/or greatly diminished signals. The cyclophilin band is highly resolved and of consistent intensity among all RNA preparations. These
characteristics are indicative of the high integrity of the RNA preparation in both the total cell and nuclear fraction extractions. Panels B and D: Normalization analyses
of β1-AR mRNA levels. Gels were subjected to phosphorimager analyses using the BioRad Molecular Imager. Normalization calculations of β1-AR mRNA levels
against corresponding cyclophilin mRNA levels were conducted. Panels B and D depicts statistical analyses of n=4 experiments. Error bars represent one standard
error. Note that the standard error bars for the histograms displaying the isoproterenol-treated and untreated controls are nearly indistinguishable from the height of the
histograms. The observed decrease (25%) in total β1-AR mRNA levels following isoproterenol treatment is statistically significant (p=0.00004; see single asterisk in
Panel B). The observed decrease (19%) in nuclear β1-AR mRNA levels following isoproterenol treatment is also statistically significant (p=0.00025; see double
asterisk in Panel D).
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in the neonatal rat cortical neurons were approximately 15%
lower than the β1-AR mRNA levels exhibited in C6 cells. It
should be noted here that in cells exhibiting low steady state
levels of β1-AR mRNAs, such as the neonatal rat cortical
neurons, measurement of β1-AR mRNA stability, and not
absolute levels of β1-AR mRNAs, would be a more sensitive
determination of post-transcriptional β1-AR regulation. As
noted in Fig. 1, we have identified significant differences in
the stability of the β1-AR mRNAs in the neonatal rat cortical
neurons following isoproterenol treatment.
3.5. UV-crosslinking/immunoblot analysis verifies that the rat
β1-AR 3′ UTR interacts with the RNA binding protein HuR
obtained from neonatal rat cortical neurons
Using extracts from neonatal rat cortical neurons, C6 cells,
and DDT1MF2 transfectants ectopically expressing rat β1-ARs,
we have demonstrated that all three extracts contain electro-
phoretically-equivalent proteins that recognize the rat β1-AR 3′
UTR probe (Fig. 5). As described in part in our previous
publication [7] and by conducting additional immunoblot
analysis, we have demonstrated that one of these molecules is
the RNA binding protein HuR. HuR is contained in all threeextracts, including the neonatal rat cortical neuron extract, and
is recognized by the rat β1-AR 3′ UTR probe. Interestingly, in
the neonatal rat cortical neuron extract, additional molecules
immunologically-related to HuR have been identified with our
HuR antibody, and also appear to be recognized by the β1-AR
3′ UTR probe. In the central nervous system, Hu genes encode
several alternatively-spliced transcripts from distinct genes
(HuB, HuC, and HuD) that produce immunologically-related
proteins with specific developmental patterns of expression
[45]. We conjecture that the additional HuR-related molecules
detected in rat cortical neurons with our HuR antibodies
represent products derived from one of the Hu genes or from an
alternatively spliced derivative. HuR interaction with the β1-AR
3′ UTR probe has also been verified using UV-crosslinking/
immunoprecipitation analysis, as displayed in our previous
publication [7]. Using a control β1-AR probe from positions
−408 to +323 (comprising a portion of the promoter and 5′
coding sequence), we demonstrated the absence of HuR
immunoreactive proteins when used with extracts from C6
cells and DDT1MF2 transfectants in the UV-crosslinking assay
[7]. This experiment provides additional supporting evidence
illustrating the importance of the β1-AR 3′ UTR sequence in
binding HuR and other molecules involved in the post-
transcriptional control of the β1-AR mRNAs.
Fig. 4. β1-AR mRNA levels in neonatal rat cortical neurons: Total RNA (Panels A and B) or nuclear RNA (Panels C and D). Panels A and C depict representative
RNase protection experiments. For both experiments, neonatal rat cortical neurons were treated independently with isoproterenol (10 μg/ml, 24 h) or leptomycin
(10 ng/ml, 24 h), or concurrently with isoproterenol (10 μg/ml, 24 h) and leptomycin (10 ng/ml, 24 h), or untreated. Panels B and D: Normalization analyses of β1-AR
mRNA levels. Gels were subjected to phosphorimager analyses using the BioRad Molecular Imager. Normalization calculations of β1-AR mRNA levels against
corresponding cyclophilin mRNA levels were conducted. Panels B and D depict statistical analyses of n=4 experiments. Error bars represent one standard error.
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using immunoprecipitated proteins that were previously UV-
crosslinked to the β1-AR 3′ UTR probe, we identified an
additional HuR immunoreactive protein of 70 kDa thatFig. 5. UV-crosslinking/immunoblot analyses of RNA–protein complexes. RNA–pr
+2084 to +2901) and extracts from C6 cells, DDT1MF2 transfectants, or neonatal
crosslinking. Control protein extracts were also electrophoresed in parallel in polyacry
phosphorimager analyses. Blots were subsequently immunostained with HuR antibod
B shows HuR immunoblot detection of proteins in control cell extracts and UV-crorecognized the β1-AR 3′ UTR probe (Fig. 6). Note that the
data displayed in Figs. 5 and 6 originate from the same
experiment, and that the immunoblot experiment displayed in
Fig. 5 is the same experiment displayed in the left portion of Fig.otein complexes containing the β1-AR probe (β1-AR sequence extending from
rat cortical neurons (25 μg in all cases) were prepared and subjected to UV-
lamide gels, and subsequently electrotransferred to nitrocellulose membranes for
ies. Panel A shows phosphorimager analyses of UV-crosslinked proteins. Panel
sslinked protein complexes.
Fig. 6. Immunoblot analyses of RNA–protein complexes immunoprecipitated with HuR antibodies prior to electrophoresis. RNA–protein complexes containing the
β1-AR probe (β1-AR sequence extending from +2084 to +2901) and extracts from C6 cells, DDT1MF2 transfectants, and neonatal rat cortical neurons (25 μg in all
cases) were prepared and subjected to UV-crosslinking. UV-crosslinked RNA–protein complexes were subjected to immunoprecipitation using either 1 μl or 4 μl of
HuR antibodies. Control protein extracts were also electrophoresed in parallel in polyacrylamide gels, and subsequently electrotransferred to nitrocellulose
membranes. Blots were also subsequently immunostained with HuR antibodies. Panel A complete immunoblot analysis displaying control protein extracts, UV-
crosslinked proteins, and immunoprecipitations using either 1 μl or 4 μl of HuR antibodies. Note that the experiment displayed in the left portion of Panel A is the same
experiment displayed in the immunoblot panel in Fig. 5, and comprise identical images. Panel B contains an overexposed image of the far right lanes in Panel A, and
illustrates the interaction of the Hu-related proteins with the β1-AR probe.
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immunoblot experiment using a HuR antibody overlay on
proteins UV-crosslinked to the β1-AR 3′ UTR probe and
immunoprecipitated with HuR antibodies prior to loading in
SDS-PAGE. We conjecture that the detection of the 70 kDa
protein using immunoblot analysis of immunoprecipitated
UV-crosslinked proteins (and not using immunoblot analysis
of UV-crosslinked proteins alone, as in Fig. 5) is the result of
the enhanced concentration of HuR-immunoreactive material
following immunoprecipitation. Also, as shown in Fig. 6,
Panel B, with an over-exposure of the immunoblot analysis
using immunoprecipitations with 4 μl of HuR antibody and
UV-crosslinked proteins from neonatal rat cortical neurons
(also as shown in Fig. 6, Panel A, far right lanes), we readily
detect the interaction of the additional Hu-related proteins with
the β1-AR 3′ UTR probe. The 70 kDa protein may represent an
HuR dimer that becomes crosslinked during UV treatment with
the β1-AR 3′ UTR probe. The potential for HuR heterodimer
formation is high, especially since HuR is known to interact with
the HuR ligands, pp32 and APRIL, and is known to form the
βARB complex composed of HuR and hnRNPA1.
3.6. Glycerol gradient centrifugation and sequential
immunoblot analyses identify high molecular weight
HuR-immunoreactive protein complexes in C6 cells
We have conducted extraction and fractionation procedures
known to preserve RNA–protein complexes and have electro-phoresed gradient fractions in nondenaturing gels. This
extraction and glycerol gradient fractionation procedure was
successfully utilized by Gallouzi et al. [46], in conjunction with
immunoprecipitation, to verify interaction of HuR with the four
HuR ligands, pp32, APRIL, SETα, and SETβ. Using the
extraction and fractionation procedure with immunoblot
analyses, we have determined that complex formation occurs
between HuR and other molecules in the C6 cell line. Using
HuR antibodies in the immunoblot analyses, we observe the
33–35 kDa HuR molecule in the upper portions of the glycerol
gradient, along with HuR immunoreactive bands of 110+ kDa
and 70 kDa, indicating multimer formation of HuR and/or
interaction of HuR with other molecules (Fig. 7, Top Panel).
Our HuR antibody has defined immunoreactivity against
the predominant HuR molecule with molecular weight of
33–35 kDa [7]. We conjecture that the HuR immunoreactive
band of 110+ kDa was visualized in this experiment, and not in
the immunoblot analysis displayed in Fig. 6, because of the
preservation of native complexes isolated in the glycerol
gradient fractionation and the use of nondenaturing gels.
Interestingly, when the blot was reprobed using CRM 1
antibodies, the 110+ kDa band was also CRM 1-immuno-
reactive, indicating that this high molecular weight band may
potentially be a protein complex composed of HuR and CRM 1
(Fig. 7, Bottom Panel). As based on information from both Figs.
6 and 7, we conjecture that the 70 kDa molecule could represent
HuR dimers or HuR complexes containing other proteins,
potentially HuR ligands pp32 or APRIL, both of which have
Fig. 8. UV-crosslinking/immunoprecipitation analyses of RNA–protein com-
plexes. RNA–protein complexes containing the β1-AR probe (β1-AR sequence
extending from +2084 to +2901) and C6 extracts (25 μg) were prepared and
subjected to UV-crosslinking and immunoprecipitation using HuR antibodies or
normal rabbit serum (NRS) control. Immunoprecipitated proteins and control
protein extracts were subjected to PAGE and subsequently electrotransferred to
nitrocellulose membranes for phosphorimager analyses. Blots were also
subsequently immunostained with CRM 1 antibodies. Panel A shows
phosphorimager analyses of immunoprecipitated UV-crosslinked proteins.
Panel B shows CRM 1 immunoblot detection of proteins in control cell extracts
and UV-crosslinked protein complexes previously immunoprecipitated with
HuR antibodies prior to electrophoresis.
Fig. 7. Glycerol gradient centrifugation and immunoblot analysis using HuR
(Panel A) and CRM 1 (Panel B) antibodies. Cell extracts known to preserve
protein complexes were prepared. The C6 cell line was chosen as the source of
extract for this experiment because of its endogenous and natural expression of
the β1-AR mRNAs and the moderately robust level of expression of HuR and
CRM 1 that enables detection of protein complexes. We have chosen not to
conduct the glycerol gradient centrifugation experiment with neonatal rat
cortical neurons because of the low level of expression of CRM 1 and the low
level of recovery of HuR–CRM 1 protein complexes from these sources. C6
cells were extracted with 5 ml lysis buffer containing 25 mMHEPES–KOH, pH
8.0, 150 mM KCl, 2 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 μg/ml aprotinin,
10 μg/ml leupeptin, 1 μg/ml pepstatin A, 20 mMNaF, and 0.1% NP-40. Extracts
were clarified by centrifugation at 40,000 rpm (SW 50.1 rotor, Beckman) for
40 min. The supernatant was loaded onto 4 ml 5–20% glycerol gradients and
centrifuged at 40,000 rpm (SW 50.1 rotor, Beckman) for 12 h. Aliquots of the
gradient fractions were subjected to polyacrylamide gel electrophoresis under
nondenaturing conditions. Blots of the nondenaturing gels were sequentially
probed with HuR (Panel A) and CRM 1 (Panel B) antibodies. The bottom panel
was cropped to focus exclusively on the cross-immunoreactivity of the 110 kDa+
band with CRM 1 antibodies.
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molecular weight of complexes containing HuR and pp32 or
APRIL would be consistent with the relative molecular weight
of the 70 kDa molecule observed in the middle portion of the
glycerol gradient.
3.7. UV-crosslinking/immunoblot analysis indicates that the
β1-AR 3′ UTR recognize HuR–CRM 1 protein complexes
The β1-AR 3′ UTR recognizes molecules of 33–35 kDa,
doublet proteins of 70–75 kDa, and a high molecular weight
molecule of 110 kDa, that are all immunoprecipitated using
HuR antibodies (Fig. 8, Left Panel). Proteins tagged with the
β1-AR 3′ UTR radioactive probe were not immunoprecipitated
using normal rabbit serum (Fig. 8, Left Panel). We have
previously identified the 33–35 kDa molecule as HuR (7; also
see Fig. 5). CRM 1 immunoblot analysis of control extracts
alone (Fig. 8, Right Panel, left lane) identifies a predominantband of 110 kDa, consistent with the calculated molecular
weight of 105 kDa for CRM 1, and a second minor component
of 70 kDa. Both molecules appear to be electrophoretically
equivalent to the 110 kDa and 70–75 kDa proteins that are
immunoprecipitated using HuR antibodies and subsequently
immunodetected by CRM 1 antibodies (Fig. 8, Right Panel,
right lane). We conjecture that at least one of the 70–75 kDa
proteins identified in this UV crosslinking/immunoprecipitation
analysis may be equivalent to the 70 kDa HuR complex
identified in the glycerol gradient centrifugation experiment
(see Fig. 7). Interestingly, at least one of 70–75 kDa molecules
retains immunoreactivity to CRM 1 antibodies; we hypothesize
that the C6 cell line may have other CRM 1-related molecules
that retain the ability to form complexes with HuR and with
other HuR ligands. This experiment provides further evidence
that the 110 kDa band is an HuR–CRM 1 protein complex and
that this complex recognizes the β1-AR 3′ UTR.
3.8. Immunoblot analyses indicate that neonatal rat cortical
neurons contain lower levels of CRM 1
Using CRM 1-specific antibodies and immunoblot analyses,
we have determined that neonatal rat cortical neurons contain
lower levels of CRM 1 compared to the DDT1MF2 cell line that
ectopicallly expresses β1-ARs (Fig. 9). The lower levels of
CRM 1 and the reduced capacity to export ARE-containing
mRNAs to the cytoplasm appears to correlate with the extended
β1-AR mRNA half-life in neonatal rat cortical neurons
compared to DDT1MF2 transfectants.
Fig. 9. CRM 1 levels in neonatal rat cortical neurons and DDT1MF2
transfectants ectopically expressing β1-ARs. Cellular extracts (25 μg) were
subjected to polyacrylamide gel electrophoresis, electrotransfer to nitrocellulose
membranes, and immunoblot analyses using CRM 1 antibodies (provided by Dr.
Gerard Grosveld). Equivalent loading of lanes was verified by Coomassie blue
staining of residual proteins retained in the polyacrylamide gel following
electrotransfer of the majority of the protein constituents.
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evidence that CRM 1 is an important determinant in the
agonist-mediated down-regulation of β1-AR mRNAs
To help determine that CRM 1 plays a distinct role in β1-AR
mRNA down-regulation, we used cell-permeable peptides
comprising the leucine-rich nuclear export signal (NES)
contained in the HuR ligands pp32 and APRIL, and recognized
by CRM 1. We also utilized peptides containing the HNS
nuclear export sequence, to serve as in vivo inhibitors of HuR
interaction with nuclear receptor importin β, and also scrambled
or mutant forms of the HNS or NES peptides (scrambled HNS
[S-HNS] or mutant NES [M-NES]) that have been demon-
strated to not interact with their respective nuclear receptors.
The nuclear receptor inhibitors appear to affect both the export
and import pathways of the ARE-containing heat shock
mRNAs. We used the DDT1MF2 transfectants for this
experiment because of its resistance to the mild cytotoxic
effects of the cell-permeable inhibitory peptides documented for
the heat shock system [34] and because of the more abundant
quantities of CRM 1 present in this cell line compared to
neonatal rat cortical neurons; we anticipated that CRM 1
inhibition in the DDT1MF2 transfectants would elicit a more
pronounced and measurable effect on β1-AR mRNA down-
regulation. Interestingly, when the DDT1MF2 transfectants are
treated with the HNS inhibitor, we observe a 30% reduction in
β1-AR mRNA levels; this reduction in β1-AR mRNA levels is
reversed when using S-HNS (Fig. 10, Panel D). When
examining β1-AR mRNA levels in cells treated with the HNS
peptide inhibitor, the best controls for comparison would be
cells treated with the scrambled HNS (S-HNS) peptide. Unlike
the untreated controls, the S-HNS treatment group would mimic
all conditions in the HNS treatment group, and would control
for ancillary effects due to cell entry of the peptides. The β1-AR
mRNA levels between the HNS and S-HNS treatment groups
are statistically significant (p=0.072). There appears to be a no
significant reduction in β1-AR mRNA levels following
inhibition with NES peptides (Fig. 10, Panel D) and treatmentwith M-NES does not induce effects on β1-AR mRNA levels
that are different from corresponding levels in the untreated
controls (p=0.313 for comparison of data group using NES
peptides versus M-NES peptides). Interestingly, the lack of
measurable effects of the NES peptide on β1-AR mRNA levels
in the DDT1MF2 transfectants appears to be inconsistent with
the observed increase in β1-AR mRNA levels following
leptomycin treatment (Fig. 2). The mechanisms of action of
leptomycin and NES peptide inhibition may not be identical.
NES treatment specifically targets the interaction of CRM 1
with the NES signals contained in the HuR ligands. Alter-
natively, leptomycin binds to CRM 1 and allosterically
displaces NES interaction from the CRM 1 nuclear export
complex [47]. Leptomycin also induces cell cycle arrest and
apoptosis in certain cancer cells [48]. Hence, while the CRM 1
target molecule for NES peptide inhibition and leptomycin
inhibition may be the same, the resultant functional effects may
potentially differ. When the DDT1MF2 transfectants are
concurrently treated with isoproterenol and the peptide
inhibitors, only the co-addition of the NES inhibitor signifi-
cantly reversed the isoproterenol-induced reduction of β1-AR
mRNA levels to levels observed for the untreated controls
(Fig. 10, Panel B) (p=0.0004 for comparison of isoproterenol
treatment group and isoproterenol plus NES peptide treatment
group). This observation is consistent with the results obtained
from the leptomycin inhibition experiments.
Interestingly, this use of the NES/CRM 1-mediated pathway
for β1-AR mRNAs following isoproterenol induction is similar
to the use of the CRM 1-mediated pathway observed for hsp70
mRNAs following heat shock [33]. Our experiment provides
evidence that HuR and its interaction with CRM 1 are important
determinants in the agonist-mediated down-regulation of β1-
AR mRNAs, and that the use of this export pathway may be
enhanced compared to the export pathways used for agonist-
independent β1-AR mRNA decay. Wang et al. [49] have also
utilized similar inhibitory peptides to demonstrate that HuR-
mediated mRNA stabilization of cytokine mRNAs is controlled
at the level of HuR nuclear export and is a critical determinant
of T cell activation.
3.10. CRM 1-mediated degradation of β1-AR mRNAs
We provide evidence that the nuclear export receptor CRM
1 moderates the steady state and agonist-mediated degradation
of the β1-AR mRNAs in neonatal rat cortical neurons and in
established cell lines. Leptomycin or peptide inhibition of
CRM 1-mediated nuclear export result in significant increases
of β1-AR mRNA levels and stability and enhanced retention in
the nucleus (Fig. 11). While β1-AR transcripts would have
increased stability during the inhibition of CRM 1-mediated
nuclear export, its retention in the nucleus may ultimately lead
to decreased availability in the cytoplasm and resultant re-
duction in synthesis of β1-ARs. Our UV-crosslinking/immu-
noprecipitation analyses and glycerol gradient fractionation
experiments provide evidence that HuR forms complexes with
other molecules, including CRM 1, and that these complexes
are recognized by the β1-AR 3′ UTR. β1-AR mRNAs are
Fig. 11. CRM 1-mediated degradation of β1-AR mRNAs. Inset box denotes enlargement of the nuclear–cytoplasmic interface, and the nucleocytoplasmic export and
agonist-mediated down-regulation of the β1-AR mRNAs.
Fig. 10. Use of nuclear export inhibitor peptides. DDT1MF2 transfectants expressing β1-ARs were treated with peptide inhibitors either individually (Panels C and D)
or concurrently with isoproterenol (Panels A and B) for 24 h. Panels A and C illustrate single representative RNase protection experiments for individual inhibitor
(Panel C) or concurrent inhibitor+ isoproterenol treatments (Panel A). β1-AR mRNA and cyclophilin mRNA levels were quantitated with the use of the BioRad
Molecular Imager. All β1-AR mRNA measurements were normalized against cyclophilin mRNA levels; mRNA intensity ratios for the nontreated controls were
assigned a value of 1.0. Panels D and B contain statistical analyses of RNase protection assay results for 3–4 culture dishes treated with either the individual inhibitors
or concurrently with inhibitor plus isoproterenol, respectively. Error bars depict the range of one standard error unit. Histograms without apparent placement of error
bars contain close sample values, with error bars nearly indistinguishable from the height of the histogram.
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translational levels, and RNA binding proteins that recognize
AU-rich sequences in the 3′ UTR can moderate nuclear export,
mRNA stability, and translational efficiency [11,30,34]. AUF-1
has been identified as an RNA degradation protein found in the
cytoplasm that recognizes the human β1-AR 3′ UTR. We
conjecture that the β1-AR mRNAs are exported to the
cytoplasm following agonist induction and that these mRNAs
may be degraded in the cytoplasm by interaction with AUF 1
(Fig. 11). mRNA stability and translation of ARE-containing
mRNAs are linked regulatory pathways. These pathways
appear to be commonly dependent on the interaction of RNA
binding proteins with AU-rich mRNAs that promote export to
the cytoplasm, the predominant site of mRNA decay and
suppression of translation.
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